000 01330nam  2200325zi 4500
0019.919198
003CaOODSP
00520230314111958
006m     o  d f      
007cr |||||||||||
008230116e202302  onc     o    f000 0 eng d
020 |a9780660471143
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-345/2023E-PDF
24500|aGuidance document : |bsale of drugs - public or Canadian Armed Forces health emergencies.
264 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cFebruary 2023.
264 4|c©2023
300 |a1 online resource (31 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Ligne directrice : la vente de drogues - urgences en matière de santé touchant le public ou les Forces armées canadiennes.
500 |a"Date adopted 2023-02-15 ; Effective date 2023-02-15".
500 |a"Pub.: 220698".
650 0|aDrug accessibility|xLaw and legislation|zCanada.
650 0|aEmergency management|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tLigne directrice : |w(CaOODSP)9.919199
85640|qPDF|s1.19 MB|uhttps://publications.gc.ca/collections/collection_2023/sc-hc/H164-345-2023-eng.pdf